Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,394,663 papers from all fields of science
Search
Sign In
Create Free Account
amycin B
Known as:
Scopafungin, 23-O-de(carboxyacetyl)-8,47-didemethyl-14,49-dimethyl-
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Guanidines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
linical Development itoring Molecular-Specific Pharmacodynamics of amycin In vivo with Inducible Gal 4 → Fluc Ther nsgenic Reporter Mice
S. Pan
,
Jeffrey Lin
,
Julie L. Prior
2010
Corpus ID: 11180786
Downlo amycin (Rap), a small-molecule inhibitor of mTOR, is an immunosuppressant, and several Rap analore cancer…
Expand
2006
2006
Leukemia Cell Line HL-60 Daunomycin with Sphinganine on the Differentiation of Human Interaction of Antileukemia Agents Adriamycin and Updated Version
Benjamin
,
Y-M.
,
Yung
,
K. Luo
,
Eric K-VV
2006
Corpus ID: 16471724
A slight induction of granulocytic differentiation of HL-60 cells oc curred after treatment with antileukemia chemotherapeutic…
Expand
2006
2006
Multidrug Resistant Human Small Cell Lung Carcinoma Cells-aniside in Atypical m-( 9-Acridinylamino ) methanesulfon-′ Topoisomerase II as a Target of VM-26 and 4 Updated
S. Jong
,
A. Kooistra
,
Élisabeth
,
G. D. Vries
,
N. Mulder
,
J. Zijlstra
2006
Corpus ID: 17471057
The Adriamycin-resistant small cell lung carcinoma cell line, t.l.(. 4/ ADR, showed large differences in cross-resistance to…
Expand
1973
1973
Survival kinetics of cultured human lymphoma cells exposed to adriamycin.
B. Drewinko
,
J. Gottlieb
Cancer Research
1973
Corpus ID: 6783394
Cultured human lymphoma cells exposed to adriamycin exhibited extreme sensitivity to the drug. When these cells were exposed to…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE